
Keywords: Safety biomarkers; Regulatory qualification; Evidentiary standards; Drug development; FDA; US Food and Drug Administration; EMA; European Medicines Agency; PMDA; Pharmaceuticals and Medical Devices Agency of Japan; FNIH; Foundation for the National Instit